The prevalence of type 2 diabetes is rising rapidly. However, the impact of diabetes on future health and life expectancy is largely underestimated. To study this, we initiated the Maastricht Study, a longitudinal population-based cohort study using a deep-phenotyping approach. In particular, my research focuses on the role of cardiometabolic changes, like diabetes and vascular dysfunction, in the development of brain diseases like cognitive decline and depression. Additionally, I investigate the psychosocial consequences of type 2 diabetes, with a focus on the impact of social networks, ethnicity and diabetes distress on the development and treatment of type 2 diabetes and its complications. Working at both MeNs and CARIM I represent the strong connection between mental and cardiovascular disease research at Maastricht University.
1999-2004 PhD in Health Sciences, Department of Internal Medicine, VU University Medical Center. PhD thesis entitled: “Pathophysiology of diabetic complications, arterial stiffness, endothelial function and inflammation.” 1999-2002 Postdoctoral training in Epidemiology, EMGO-institute, VU University, Amsterdam, registered Epidemiologist B at the SMBWO in the Netherlands since 2004. 1995 – 1999 MSc Biomedical Science, Faculty of Medicine, State University of Leiden, Leiden, the Netherlands
Diabetes epidemiology, observational cohort studies, neuroepidemiology